title: Renal outcomes in the ONTARGET study.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Gallieni
authors.forename: Mario
authors.initials: M
authors.lastname: Cozzolino
authors.forename: Diego
authors.initials: D
authors.lastname: Brancaccio
authors.forename: Marcello
authors.initials: M
authors.lastname: Giovannini
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D012084:Renin-Angiotensin System / Q000187:drug effects*; D014652:Vascular Diseases / Q000188:drug therapy
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors